Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience

• Kathryn T. Maples,
• Kevin H. Hall,
• Nisha S. Joseph,
• Craig C. Hofmeister,
• Vikas Gupta,
• Madhav V. Dhodapkar,
• Jonathan L. Kaufman,
• Ajay K. Nooka,
• Sagar Lonial

Affiliations

Kathryn T. Maples

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine

Kevin H. Hall

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine

Nisha S. Joseph

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine

Craig C. Hofmeister

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine

Vikas Gupta

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine

Madhav V. Dhodapkar

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine

Jonathan L. Kaufman

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine

Ajay K. Nooka

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine

Sagar Lonial

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine